GSK, Roche Breast-Cancer Treatments Work Better Combined, Study Shows

Combining GlaxoSmithKline’s Tykerb drug with Roche Holding’s Herceptin to treat breast cancer was almost twice as effective as single-drug therapy, according to researchers in a 23-country clinical trial.
Bloomberg